Omada Health
Healthcare
Founded: 2011
Last Round Valuation: $1.02B
Omada Health is a leading digital health company focused on improving lives through personalized, evidence-based programs. By combining innovative technology with human support, Omada Health helps individuals make sustainable lifestyle changes, manage chronic conditions, and achieve better health outcomes. Their comprehensive platform empowers individuals to take control of their health and well-being, fostering positive behavior change and promoting a sense of community and support.
Omada Health Overview:
Omada Health is a prominent digital health company that offers comprehensive and personalized solutions for managing chronic diseases and improving overall well-being. Founded in 2011, the company has established itself as a leader in the field, combining innovative technology, behavioral science, and human support to deliver effective and scalable programs.
Omada Health's primary focus is on chronic conditions such as diabetes, hypertension, and obesity, which have a significant impact on individuals' health and quality of life. Their evidence-based digital programs are designed to address the underlying causes of these conditions and support individuals in making lasting behavior changes.
At the core of Omada Health's approach is their user-friendly platform, which provides participants with access to a range of tools and resources. These include interactive lessons, goal tracking, food and activity logging, and personalized feedback. The platform also features social support elements, allowing individuals to connect with peers, share experiences, and receive encouragement from a supportive community.
One of the key strengths of Omada Health is their team of health coaches and experts who provide personalized guidance and support throughout the program. These professionals work closely with participants to develop tailored action plans, offer ongoing feedback, and address any barriers or challenges faced along the way. Through regular communication and check-ins, they help individuals stay motivated and accountable to their health goals.
Omada Health's programs are built on rigorous scientific research and have been shown to deliver positive health outcomes. They are continuously refined and updated based on real-world data and feedback to ensure the highest level of effectiveness. The company's commitment to evidence-based practices and continuous improvement has earned them recognition and partnerships with leading healthcare organizations, employers, and health plans.
In addition to their core programs for chronic disease management, Omada Health has expanded its offerings to address other areas of health and well-being. This includes programs for mental health, stress management, and healthy lifestyles. By taking a holistic approach to health, Omada Health aims to empower individuals to make comprehensive lifestyle changes that lead to long-term well-being.
Overall, Omada Health is at the forefront of leveraging technology and human support to revolutionize the way chronic diseases are managed and prevented. Their comprehensive and personalized programs empower individuals to take control of their health, make sustainable behavior changes, and ultimately live healthier and more fulfilling lives.
Founders:
Sean Duffy
Adrian James
Andrew DiMichele
Christina Wodtke
Top Investors:
Andreessen Horowitz
Cigna Ventures
Civilization Ventures
Designer Fund
Fidelity
Founder Collective
GE Ventures
HealthTech Capital
Humana Ventures
IDEO Futures
Kaiser Permanente Ventures
Kapor Capital
New Enterprise Associates
Norwest Venture Partners
Perceptive Advisors
Providence Ventures
Rock Health
Sanofi Genzyme Bioventures
The Vertical Group
TriplePoint Capital
US Venture Partners
Wellington Management
aMoon
dRx Capital
Funding History:
Date | Share Type | Amount Raised | Raised to Date | Issue Price | Post Money Valuation | Key Investors |
---|---|---|---|---|---|---|
Feb 2022 | Series E | $192MM | $459.88MM | $6.00 | $1.02B | Fidelity, aMoon, Perceptive Advisors |
Mar 2021 | Series D-1 | $27MM | $267.88MM | $6.00 | $780.77MM | Undisclosed Investors |
May 2020 | Series D | $112.47MM | $240.88MM | $5.04 | $612.85MM | Perceptive Advisors, Andreessen Horowitz, Cigna Ventures |
May 2017 | Series C-1 | $49.99MM | $128.41MM | $3.74 | $320.25MM | Cigna, Civilization Ventures, Sanofi Genzyme BioVentures |
Oct 2015 | Series C | $48.67MM | $78.42MM | $3.16 | $216.43MM | Norwest Venture Partners, Providence Ventures, Humana Ventures |
Apr 2014 | Series B | $23.33MM | $29.76MM | $1.18 | $60.57MM | Andreessen Horowitz, Kaiser Permanente Ventures, U.S. Venture Partners |
Mar 2013 | Series A | $6.43MM | $6.43MM | $0.53 | $16.11MM | U.S. Venture Partners, The Vertical Group, Founder Collective |